BiBBInstruments developed the CE-marked electromechanical biopsy instruments for endoscopic use, which aims to improve the current diagnosis of serious and difficult-to-diagnose tumours. The directed share issue, conducted earlier this year, creates opportunities for the company to continue its development and present several clinical news in the coming year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 SEK | +3.25% | +19.17% | +81.01% |
05-20 | Sweden's BiBBInstruments to Issue SEK10 Million Shares | MT |
05-17 | BiBBInstruments Expands Clinical Evaluation of Endoscopy Instrument in Scandinavia | MT |
1st Jan change | Capi. | |
---|---|---|
+81.01% | 14.39M | |
-25.18% | 16.87B | |
-40.23% | 2.95B | |
+15.23% | 1.82B | |
-5.65% | 1.57B | |
+33.13% | 1.35B | |
-18.62% | 938M | |
-25.88% | 848M | |
-26.78% | 613M | |
+24.29% | 596M |
- Stock Market
- Equities
- BIBB Stock
- News BiBBInstruments AB
- BiBBInstruments Develops the CE-Marked Electromechanical Biopsy Instruments for Endoscopic Use